Dr. James Gillespie, PhD, JD, MPA
President & Co-Founder of CHI
Dr. James J. Gillespie, PhD, JD, MPA, is a researcher and scholar, with an expertise focusing on the strategy of the life sciences sectors. Dr. Gillespie is also CEO of the Chicago Life Sciences Consortium, a resource for early and middle stage biotechnology, medical device, and healthcare companies in the metropolitan Chicago area. He is Co-Leader of the Working Group on Innovation & Interoperability (WGII),a healthcare analytics project featuring executives from Blue Cross Blue Shield Association, Computer Sciences Corporation, Healthcare Information and Management Systems Society, Metropolitan Chicago Healthcare Council, and Walgreens Corporation. The WGII aims to leverage large claims, clinical, and prescription databases for analytics to improve healthcare quality, access, and out-comes. Dr. Gillespie chairs the annual symposium “Emerging Markets in Life Sciences Symposium: The Role of Relationships” hosted by Microsoft Corporation and co-sponsored by Pharmaceutical Executive Magazine.
He founded and chairs the annual symposium “Diversity, Inclusion, & Life Sciences”, which has become the top annual event focused specifically on the interface between diversity, inclusion, and the global life sciences industry.
Dr. Gillespie’s research has appeared in Academy of Management Review, American Behavioral Scientist, European Journal of Social Psychology, Federal Reserve Bank, Harvard Business Review, and Strategic Management Journal. His education includes Northwestern University Kellogg School of Management, M.A., Ph.D.; Harvard University School of Law, J.D.; Princeton University Woodrow Wilson School of Public Policy, M.P.A.; Massachusetts Institute of Technology, B.S.; and Carnegie Mellon University.